Pretoria, 11 March 2024 – The Communications and Public Relations Unit has again re-evaluated the navigation of the South African Health Products Regulatory Authority (SAHPRA) website for easier access to key documentation and E-Services. ...
Pretoria, 11 March 2024 – On 05 January 2023, the COVID Care Alliance NPC and other applicants brought an urgent court application against the South African Health Products Regulatory Authority (SAHPRA), including the President of the Republic of South Africa and others to prevent people from...
Pretoria, 19 February 2024 – The Department of Health has noted a misleading voice-note making rounds on social media platforms claiming that people who vaccinated against COVID-19 are dying due to the vaccine. The voice-note promotes the use of an unregistered, over-the-counter product called “Nature`s Choice...
AUDA-NEPAD has published its 2023 Highlights Edition on African Medicines Regulatory Harmonization (AMRH) featuring articles on: Harmony in healthcare 2023 highlights of the Good Manufacturing Practice Technical Committee Evaluation of Medicinal Products Technical Committee virtual meeting Plans for the College for African Regulatory Science Professionals Milestones in domesticating the AU...
Pretoria, 12 January 2024 – The South African Health Products Regulatory Authority (SAHPRA) has signed a Memorandum of Understanding (MoU) with the Medicines Control Authority of Zimbabwe (MCAZ). The MoU between SAHPRA and MCAZ will allow the regulators to develop a cooperative partnership towards ensuring access...
2024 | Embracing new partnerships and overcoming challenges As we begin 2024, I take this opportunity to wish all our stakeholders a wonderful New Year ahead. May we continue to develop partnerships, partake in robust engagements, and strive to achieve our intended goals. I want to thank...
There have been several cases around the world in which Tranexamic acid has been administered intrathecally in error instead of the local anaesthetic agent, bupivacaine.(1) Postpartum haemorrhage is the third most common cause of death in obstetric practice in developing countries. Tranexamic acid is life-saving in...
Pretoria, 19 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) is aware of the product Lubri-A (Sterile Lubricating Jelly) manufactured by Electro-Spyres, classified as Class B medical device and currently being distributed across the country. SAHPRA has been informed of multiple complaints received...
Pretoria, 14 December 2023 -The South Africa Health Products Regulatory Authority (SAHPRA), in collaboration with Pharmacometrics Africa and the Department of Pharmacy and Pharmacology at the University of Witwatersrand, is responsive to the evolving and advancing healthcare technology innovation by developing relevant training for its...
Pretoria, 13 December 2023 – The South African Health Products Regulatory Authority (SAHPRA) recently released a media statement on the falsified Ozempic products currently being sold on the market and online, specifically unauthorised Ozempic/semaglutide-containing products. SAHPRA has registered one product which contains semaglutide called Ozempic. There...
